Ultragenyx Pharmaceutical
RARE
#5033
Rank
โ‚ฌ1.64 B
Marketcap
16,17ย โ‚ฌ
Share price
6.17%
Change (1 day)
-42.95%
Change (1 year)

EPS for Ultragenyx Pharmaceutical (RARE)

EPS in 2026 (TTM): -4,50ย โ‚ฌ

According to Ultragenyx Pharmaceutical's latest financial reports the company's current EPS (TTM) is -4,73ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -5,33ย โ‚ฌ an increase over its 2024 EPS that were of -5,78ย โ‚ฌ.

EPS history for Ultragenyx Pharmaceutical from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-4,50ย โ‚ฌ-15.51%
2025-5,33ย โ‚ฌ-7.89%
2024-5,78ย โ‚ฌ-23.89%
2023-7,60ย โ‚ฌ-17.61%
2022-9,22ย โ‚ฌ50.67%
2021-6,12ย โ‚ฌ113.69%
2020-2,86ย โ‚ฌ-55.9%
2019-6,49ย โ‚ฌ82.56%
2018-3,56ย โ‚ฌ-45.15%
2017-6,49ย โ‚ฌ14.68%
2016-5,66ย โ‚ฌ
2014-2,12ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Lexicon Pharmaceuticals
LXRX
-0,13ย โ‚ฌ-97.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-0,01824ย โ‚ฌ-99.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
-0,10ย โ‚ฌ-97.88%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
-0,08209ย โ‚ฌ-98.27%๐Ÿ‡บ๐Ÿ‡ธ USA